Literature DB >> 16300985

Real-time analysis of human immunodeficiency virus type 1 Env-mediated membrane fusion by fluorescence resonance energy transfer.

Rika A Furuta1, Masao Nishikawa, Jun-ichi Fujisawa.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env)-mediated membrane fusion occurs as a sequence of events that is triggered by CD4 binding to the Env gp120 subunit. In this study, we analyzed the dynamics of Env-mediated membrane fusion at the single-cell level using fluorescent fusion proteins and confocal laser fluorescent microscopy. Either enhanced cyan or yellow fluorescent protein (CFP and YFP, respectively) was fused to the end of the cytoplasmic regions of the HIV-1 receptors (CD4 and CCR5) and Env proteins. Real-time imaging of membrane fusion mediated by these recombinant proteins revealed that the kinetics of fusion in our system was faster than that previously reported. Analysis of the receptor interaction by fluorescence resonance energy transfer (FRET) at the single-cell level demonstrated a tendency for oligomerization of CD4-CD4, but not of CD4-CCR5, in the absence of Env-expressing cells. However, when Env-expressing cells attached to the receptor cells, FRET produced by CD4-CCR5 interaction was increased; the FRET intensity began to decline before the formation of the fusion pore. These changes in FRET may represent the temporal association of these receptors, triggered by gp120 binding, and their dissociation during the formation of the fusion pore. In addition, the FRET analysis of receptor interactions in the presence of fusion inhibitors showed that not only inhibitors acting on CCR5 but also the gp41-derived peptide T-20 interfered with CD4-CCR5 interaction during fusion. These data suggest that T-20 could affect the formation of Env-receptors complexes during the membrane fusion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16300985     DOI: 10.1016/j.micinf.2005.08.004

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  7 in total

1.  Structural and Functional Study of Apoptosis-linked Gene-2·Heme-binding Protein 2 Interactions in HIV-1 Production.

Authors:  Jing Ma; Xianfeng Zhang; Yanbin Feng; Hui Zhang; Xiaojun Wang; Yonghui Zheng; Wentao Qiao; Xinqi Liu
Journal:  J Biol Chem       Date:  2016-10-26       Impact factor: 5.157

Review 2.  Live cell imaging of the HIV-1 life cycle.

Authors:  Edward M Campbell; Thomas J Hope
Journal:  Trends Microbiol       Date:  2008-10-30       Impact factor: 17.079

3.  Comparative analysis of the fusion efficiency elicited by the envelope glycoprotein V1-V5 regions derived from human immunodeficiency virus type 1 transmitted perinatally.

Authors:  Hongyan Guo; Levon G Abrahamyan; Chang Liu; Mackenzie Waltke; Yunqi Geng; Qimin Chen; Charles Wood; Xiaohong Kong
Journal:  J Gen Virol       Date:  2012-09-05       Impact factor: 3.891

4.  Design of Small Molecules with HIV Fusion Inhibitory Property Based on Gp41 Interaction Assay.

Authors:  Soroush Sardari; Kayhan Azadmanesh; Fereidoun Mahboudi; Asghar Davood; Ruhollah Vahabpour; Rezvan Zabihollahi; Hosna Gomari
Journal:  Avicenna J Med Biotechnol       Date:  2013-04

5.  CD4-specific designed ankyrin repeat proteins are novel potent HIV entry inhibitors with unique characteristics.

Authors:  Andreas Schweizer; Peter Rusert; Livia Berlinger; Claudia R Ruprecht; Axel Mann; Stéphanie Corthésy; Stuart G Turville; Meropi Aravantinou; Marek Fischer; Melissa Robbiani; Patrick Amstutz; Alexandra Trkola
Journal:  PLoS Pathog       Date:  2008-07-25       Impact factor: 6.823

6.  Enhanced bactericidal potency of nanoliposomes by modification of the fusion activity between liposomes and bacterium.

Authors:  Yufan Ma; Zhao Wang; Wen Zhao; Tingli Lu; Rutao Wang; Qibing Mei; Tao Chen
Journal:  Int J Nanomedicine       Date:  2013-06-28

7.  Monitoring of HIV-1 envelope-mediated membrane fusion using modified split green fluorescent proteins.

Authors:  Jianqi Wang; Naoyuki Kondo; Yufei Long; Aikichi Iwamoto; Zene Matsuda
Journal:  J Virol Methods       Date:  2009-06-25       Impact factor: 2.014

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.